Suppr超能文献

枸橼酸氯米酚和人绒毛膜促性腺激素在恢复性腺功能减退症患者的睾酮水平方面均有效:一项短期随机研究。

Clomiphene citrate and human chorionic gonadotropin are both effective in restoring testosterone in hypogonadism: a short-course randomized study.

机构信息

Urology and Andrology Department, Elaj Medical Centres, Jeddah, Saudi Arabia.

King's College Hospital, London, UK.

出版信息

BJU Int. 2018 Nov;122(5):889-897. doi: 10.1111/bju.14401. Epub 2018 Jun 14.

Abstract

OBJECTIVES

To compare serum testosterone response and symptom improvement in men with hypogonadism in response to treatment with clomiphene citrate (CC), human chorionic gonadotropin (hCG), or a combination of both therapies.

PATIENTS AND METHODS

A total of 282 men with hypogonadism, wishing to preserve their fertility, were randomized to one of three treatment arms: CC 50 mg (n = 95); 5000 IU hCG injections twice weekly (n = 94); or a combination of both therapies (CC + hCG; n = 94). All participants had complete medical history and had undergone thorough physical examination, including body mass index (BMI) assessment. Laboratory tests included serum total testosterone and glycated haemoglobin (HbA1c) measurements. Quantitative Androgen Deficiency in the Aging Male (qADAM) questionnaire scores were also recorded. Morning samples of total serum testosterone levels were assessed at three time points: baseline, 1 and 3 months.

RESULTS

Testosterone levels increased at 1 and 3 months in all three groups. The mean baseline testosterone level was 2.31 ± 0.66 nmol/L, BMI was 30.8 ± 6.2 kg/m , and qADAM score was 20.5 ± 3.8. Testosterone levels increased in all groups at all time points, with a final mean value of 5.17 ± 1.77 nmol/L (223% increase) with no statistically significant difference among the groups. qADAM scores had increased in all groups at 1 month (CC group: 6.36; hCG group: 5.08; CC + hCG group: 7.26) and at 3 months (CC group: 12.73; hCG group: 11.82; CC + hCG group: 15.13) with a significant difference in intergroup analysis for the CC + hCG group compared with the other two groups (P < 0.01).

CONCLUSIONS

All three treatments were equally effective in restoring testosterone levels. Single-agent CC is simple, cheap and may be used as treatment for hypogonadism when maintenance of fertility is desired. This approach seems to be as effective as either hCG alone or a combination of hCG and CC.

摘要

目的

比较氯米芬(CC)、人绒毛膜促性腺激素(hCG)或两者联合治疗对低促性腺激素血症男性的血清睾酮反应和症状改善。

方法

共有 282 名希望保留生育能力的低促性腺激素血症男性患者被随机分为三组治疗:CC 50mg(n=95);每周两次注射 5000IU hCG(n=94);或两种疗法联合(CC+hCG;n=94)。所有参与者均接受完整的病史和全面的体格检查,包括体重指数(BMI)评估。实验室检查包括血清总睾酮和糖化血红蛋白(HbA1c)测量。还记录了定量雄激素缺乏在老年男性(qADAM)问卷评分。在三个时间点评估总血清睾酮水平的清晨样本:基线、1 个月和 3 个月。

结果

三组患者的睾酮水平在 1 个月和 3 个月时均升高。平均基线睾酮水平为 2.31±0.66nmol/L,BMI 为 30.8±6.2kg/m2,qADAM 评分为 20.5±3.8。所有组在所有时间点的睾酮水平均升高,最终平均值为 5.17±1.77nmol/L(223%增加),组间无统计学差异。所有组在 1 个月时 qADAM 评分均升高(CC 组:6.36;hCG 组:5.08;CC+hCG 组:7.26)和 3 个月时(CC 组:12.73;hCG 组:11.82;CC+hCG 组:15.13),CC+hCG 组与其他两组相比,组间分析差异有统计学意义(P<0.01)。

结论

三种治疗方法在恢复睾酮水平方面同样有效。单一药物 CC 简单、便宜,当需要维持生育能力时,可作为低促性腺激素血症的治疗方法。这种方法似乎与单独使用 hCG 或 hCG 和 CC 联合使用一样有效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验